Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Reprod Domest Anim ; 59(7): e14663, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38990011

ABSTRACT

The present study was conducted to investigate the global proteome of 8-day-old equine blastocysts. Follicular dynamics of eight adult mares were monitored by ultrasonography and inseminated 24 h after the detection of a preovulatory follicle. Four expanded blastocysts were recovered, pooled, and subjected to protein extraction and mass spectrometry. Protein identification was conducted based on four database searches (PEAKS, Proteome Discoverer software, SearchGUI software, and PepExplorer). Enrichment analysis was performed using g:Profiler, Panther, and String platforms. After the elimination of identification redundancies among search tools (at three levels, based on identifiers, peptides, and cross-database mapping), 1977 proteins were reliably identified in the samples of equine embryos. Proteomic analysis unveiled robust metabolic activity in the 8-day equine embryo, highlighted by an abundance of proteins engaged in key metabolic pathways like the TCA cycle, ATP biosynthesis, and glycolysis. The prevalence of chaperones among highly abundant proteins suggests that regulation of protein folding, and degradation is a key process during embryo development. These findings pave the way for developing new strategies to improve equine embryo media and optimize in vitro fertilization techniques.


Subject(s)
Blastocyst , Proteome , Animals , Horses/embryology , Female , Blastocyst/metabolism , Embryonic Development , Prospective Studies , Proteomics , Fertilization in Vitro/veterinary
2.
Front Oncol ; 12: 833068, 2022.
Article in English | MEDLINE | ID: mdl-35814389

ABSTRACT

Myelodysplastic syndrome (MDS) is a hematological disorder characterized by abnormal stem cell differentiation and a high risk of acute myeloid leukemia transformation. Treatment options for MDS are still limited, making the identification of molecular signatures for MDS progression a vital task. Thus, we evaluated the proteome of bone marrow plasma from patients (n = 28) diagnosed with MDS with ring sideroblasts (MDS-RS) and MDS with blasts in the bone marrow (MDS-EB) using label-free mass spectrometry. This strategy allowed the identification of 1,194 proteins in the bone marrow plasma samples. Polyubiquitin-C (UBC), moesin (MSN), and Talin-1 (TLN1) showed the highest abundances in MDS-EB, and centrosomal protein of 55 kDa (CEP55) showed the highest relative abundance in the bone marrow plasma of MDS-RS patients. In a follow-up, in the second phase of the study, expressions of UBC, MSN, TLN1, and CEP55 genes were evaluated in bone marrow mononuclear cells from 45 patients by using qPCR. This second cohort included only seven patients from the first study. CEP55, MSN, and UBC expressions were similar in mononuclear cells from MDS-RS and MDS-EB individuals. However, TLN1 gene expression was greater in mononuclear cells from MDS-RS (p = 0.049) as compared to MDS-EB patients. Irrespective of the MDS subtype, CEP55 expression was higher (p = 0.045) in MDS patients with abnormal karyotypes, while MSN, UBC, and TALIN1 transcripts were similar in MDS with normal vs. abnormal karyotypes. In conclusion, proteomic and gene expression approaches brought evidence of altered TLN1 and CEP55 expressions in cellular and non-cellular bone marrow compartments of patients with low-risk (MDS-RS) and high-risk (MDS-EB) MDSs and with normal vs. abnormal karyotypes. As MDS is characterized by disrupted apoptosis and chromosomal alterations, leading to mitotic slippage, TLN1 and CEP55 represent potential markers for MDS prognosis and/or targeted therapy.

3.
Reprod Domest Anim ; 56(4): 586-603, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33460477

ABSTRACT

The present study was conducted to decipher the proteome of in vivo-produced pre-implantation ovine embryos. Ten locally adapted Morana Nova ewes received hormonal treatment and were inseminated 12 hr after ovulation. Six days later, 54 embryos (morula and blastocyst developmental state) were recovered from eight ewes and pooled to obtain sufficient protein for proteomic analysis. Extracted embryo proteins were analysed by LC-MS/MS, followed by identification based on four database searches (PEAKS, Proteome Discoverer software, SearchGUI software, PepExplorer). Identified proteins were analysed for gene ontology terms, protein clusters and interactions. Genes associated with the ovine embryo proteome were screened for miRNA targets using data sets of TargetScan (http://www.targetscan.org) and mIRBase (http://www.mirbase.org) servers. There were 667 proteins identified in the ovine embryos. Biological processes of such proteins were mainly related to cellular process and regulation, and molecular functions, to binding and catalytic activity. Analysis of the embryo proteins revealed 49 enriched functional clusters, linked to energy metabolism (TCA cycle, pyruvate and glycolysis metabolism), zona pellucida (ZP), MAPK signalling pathway, tight junction, binding of sperm to ZP, translation, proteasome, cell cycle and calcium/phospholipid binding. Sixteen miRNAs were related to 25 pre-implantation ovine embryo genes, all conserved in human, bovine and ovine species. The interaction network generated by miRNet showed four key miRNAs (hsa-mir-106b-5p; hsa-mir-30-5p; hsa-mir-103a-5p and hsa-mir-106a-5p) with potential interactions with embryo-expressed genes. Functional analysis of the network indicated that miRNAs modulate genes related to cell cycle, regulation of stem cell and embryonic cell differentiation, among others. Retrieved miRNAs also modulate the expression of genes involved in cell signalling pathways, such as MAPK, Wnt, TGF-beta, p53 and Toll-like receptor. The current study describes the first major proteomic profile of 6-day-old ovine embryos produced in vivo, setting a comprehensive foundation for our understanding of embryo physiology in the ovine species.


Subject(s)
Embryo, Mammalian/chemistry , Proteome/analysis , Sheep, Domestic/embryology , Animals , Female , Insemination, Artificial/veterinary , Male , MicroRNAs/genetics , Proteome/genetics , Sheep, Domestic/genetics , Sheep, Domestic/metabolism
4.
Sci Rep ; 10(1): 14661, 2020 09 04.
Article in English | MEDLINE | ID: mdl-32887897

ABSTRACT

The present study investigated the seminal plasma proteome of Holstein bulls with low (LF; n = 6) and high (HF; n = 8) sperm freezability. The percentage of viable frozen-thawed sperm (%ViableSperm) determined by flow cytometry varied from -2.2 in LF to + 7.8 in HF bulls, as compared to the average %ViableSperm (54.7%) measured in an 860-sire population. Seminal proteins were analyzed by label free mass spectrometry, with the support of statistical and bioinformatics analyses. This approach identified 1,445 proteins, associated with protein folding, cell-cell adhesion, NADH dehydrogenase activity, ATP-binding, proteasome complex, among other processes. There were 338 seminal proteins differentially expressed (p < 0.05) in LF and HF bulls. Based on multivariate analysis, BSP5 and seminal ribonuclease defined the HF phenotype, while spermadhesin-1, gelsolin, tubulins, glyceraldehyde-3-phosphate dehydrogenase, calmodulin, ATP synthase, sperm equatorial segment protein 1, peroxiredoxin-5, secretoglobin family 1D and glucose-6-phosphate isomerase characterized the LF phenotype. Regression models indicated that %ViableSperm of bulls was related to seminal plasma peroxiredoxin-5, spermadhesin-1 and the spermadhesin-1 × BSP5 interaction (R2 = 0.84 and 0.79; p < 0.05). This report is the largest dataset of bovine seminal plasma proteins. Specific proteins of the non-cellular microenvironment of semen are potential markers of sperm cryotolerance.


Subject(s)
Cryopreservation/methods , Proteome , Semen Analysis/methods , Semen Preservation/methods , Semen/metabolism , Spermatozoa/metabolism , Animals , Biomarkers/metabolism , Cattle , Cell Survival , Fertility , Fertility Preservation/methods , Gene Ontology , Male , Phenotype , Proteomics/methods
5.
Theriogenology ; 94: 59-63, 2017 May.
Article in English | MEDLINE | ID: mdl-28407861

ABSTRACT

Reproductive tract development during puberty is critical to reproductive performance, and the light is crucial in this process in birds. However, in male quail, there is little information on the effects of types of lamps, more specifically the wavelength emitted. Thus, the objective was to evaluate the effects of types of lamps on the reproductive performance of male Japanese quail (Coturnix coturnix japonica). Two hundred and forty male quail were exposed to six different types of lamp (incandescent, white fluorescent, or blue, white, red or green LED). The experimental design was completely randomized with six treatments and five replicates of one quail. Quail were slaughtered on days 35, 47, 57, 71 and 123 to evaluate the development of testes. On day 117, semen samples were analyzed and fertilized eggs were incubated. Body weight of the quails was influenced (P < 0.01) by lamps only until the 47 days of age. Higher body weight until this age were observed with incandescent, blue and green LED bulbs. Fluorescent and red LED bulbs propitiated (P < 0.05) early testicular development of quails but, at 57 days of age, higher testicular development was obtained (P < 0.01) whit white LED bulbs. Lower testicular development was observed (P < 0.01) at 123 days of age with the red LED. No influence of different types of lamps was observed (P > 0.05) on the quality of semen nor on the fertility rates of quail. It is concluded that lamps can influence the histological reproductive characteristics of male quails, but without influencing the semen quality. Fluorescent bulbs and red LED seem to anticipate the sexual maturity, but the white LED results in higher testicular development at 57 days of age.


Subject(s)
Coturnix/growth & development , Sexual Maturation/radiation effects , Testis/radiation effects , Animals , Body Weight/radiation effects , Fertility/radiation effects , Male , Random Allocation , Semen Analysis/veterinary , Testis/growth & development
6.
Bioorg Med Chem ; 23(9): 2148-2158, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25842364

ABSTRACT

Phytochemicals play an important role in cancer therapy. Hispolon and 26 of its analogs (9 known and 17 new) were synthesized and evaluated for their antiproliferative activities in a panel of six independent human cancer cell lines using the in vitro cell-based MTT assay. Among the hispolon analogs tested, compound VA-2, the most potent overall, produced its most significant effect in the colon cancer cell lines HCT-116 (IC50 1.4 ± 1.3 µM) and S1 (IC50 1.8 ± 0.9 µM) compared to its activity in the normal HEK293/pcDNA3.1 cell line (IC50 15.8±3.7 µM; p<0.01 for each comparison). Based on our results, VA-2 was about 9- to 11-times more potent in colon cancer cells and 2- to 3-times more potent in prostate cancer cells compared to HEK293/pcDNA3.1 cells. Morphological analysis of VA-2 showed significant reduction of cell number, while the cells' sizes were also markedly increased and were obvious at 68 h of treatment with 1 µM in HCT-116 (colon) and PC-3 (prostate) cancer cells. A known analog, compound VA-4, prepared by simple modifications on the aromatic functional groups of hispolon, inhibited prostate and colon cancer cell lines with IC50 values <10 µM. In addition, hispolon isoxazole and pyrazole analogs, VA-7 and VA-15 (known), respectively, have shown significant activity with the mean ICv values in the range 3.3-10.7 µM in all the cancer cell lines tested. Activity varied among the analogs in which aromatic functional groups and ß-diketone functional groups are modified. But the activity of analogs VA-16 to VA-27 was completely lost when the side chain double-bond was hydrogenated indicating the crucial role of this functionality for anticancer activity. Furthermore, many of the compounds synthesized were not substrates for the ABCB1-transporter, the most common cause of multidrug resistance in anti-cancer drugs, suggesting they may be more effective anticancer agents.


Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Catechols/pharmacology , Drug Design , Animals , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Catechols/chemical synthesis , Catechols/chemistry , Cell Proliferation/drug effects , Cells, Cultured , Dogs , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , HEK293 Cells , Humans , MCF-7 Cells , Madin Darby Canine Kidney Cells/drug effects , Mice , Molecular Structure , NIH 3T3 Cells , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...